Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.
In order to evaluate the importance of suppuration, persistent infection, and scar formation in the evolution of Escherichia coli chronic pyelonephritis, we treated rats with different antibiotic regimens at different stages of the disease. The results show that (a) if acute suppurative pyelonephritis is aborted with early antibiotic therapy, chronic pyelonephritis is prevented; (b) chronic pyelonephritis can develop even after eradication of infection if acute suppuration persists beyond 3 days; (c) persistent infection does not lead to chronic pyelonephritis, if the acute suppuration is suppressed; and (d) residual infection, antigen-load, antibody, and(or) cell-dependent autoimmune processes did not play a significant role. We interpret these results as evidence that the pathologic entity recognized as chronic pyelonephritis results from kidney damage, scarring and shrinkage secondary to acute suppuration.
D000208:Acute Disease; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000032:analysis; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D008297:Male; D011704:Pyelonephritis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D051381:Rats; D013492:Suppuration / Q000188:drug therapy / Q000276:immunology; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial